cbdMD (YCBD) NonCurrent Deferred Liabilities: $0.00 Mil (As of Mar. 2026)


YCBD cbdMD Inc YCBD
39 GF Score
Price $0.79
GF Value $0.16
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is cbdMD NonCurrent Deferred Liabilities?

cbdMD YCBD -2.80% 39 NonCurrent Deferred Liabilities is $0.00 Mil as of Mar. 2026. GuruFocus rates YCBD with a GF Score™ of 39/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

cbdMD's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $0.00 Mil.

cbdMD NonCurrent Deferred Liabilities Related Terms

cbdMD NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for cbdMD's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

cbdMD NonCurrent Deferred Liabilities Chart

cbdMD Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

cbdMD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
YCBD
39GF Score
cbdMD Inc YCBD
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $0.00 Mil mean?
cbdMD (YCBD) has a NonCurrent Deferred Liabilities of $0.00 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on cbdMD and its competitors.
Is cbdMD's NonCurrent Deferred Liabilities too high?
cbdMD's current NonCurrent Deferred Liabilities is $0.00 Mil. Overall, cbdMD has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does cbdMD's NonCurrent Deferred Liabilities compare to AKAN and GELS?
cbdMD's NonCurrent Deferred Liabilities of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Drug Manufacturers company?
A good NonCurrent Deferred Liabilities depends on the Drug Manufacturers industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on cbdMD and its competitors. cbdMD's current NonCurrent Deferred Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is cbdMD stock overvalued right now?
Based on GuruFocus' analysis, cbdMD (YCBD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.79 — trading 392.1% above its estimated fair value. The current NonCurrent Deferred Liabilities is $0.00 Mil. cbdMD's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For cbdMD (YCBD), the current NonCurrent Deferred Liabilities is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is cbdMD (YCBD) Overvalued in 2026?

Based on GuruFocus' analysis, cbdMD stock appears to be overvalued. The current stock price of $0.79 is trading 392.1% above its estimated GF Value™ of $0.16. GuruFocus considers cbdMD to be Significantly Overvalued.

Key valuation signals for YCBD:

  • NonCurrent Deferred Liabilities: $0.00 Mil
  • GF Value™: $0.16 vs. price of $0.79 (392.1% above fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

cbdMD Business Description

Address 2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
39GF Score

Get the complete analysis for YCBD

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.79
Price
$0.16
GF Value